Prospective follow-up of rituximab treatment in 158 patients with refractory autoimmune diseases: Tolerance and safety data from the french registry air (autoimmunity and rituximab)

被引：0
|
作者：
Gottenberg, J. [1 ]
Combe, B. [2 ]
Dougados, M. [3 ]
Berthelot, J. [4 ]
Hachullas, E. [5 ]
Guillevins, L. [6 ]
Pallot-Prades, B. [7 ]
Costedoat-Chalumeaue, N. [8 ]
DeBandt, M. [9 ]
Sordet, C. [10 ]
Fain, O. [11 ]
Larroche, C. [12 ]
Gaudin, P. [13 ]
Ardizzonne, M. [14 ]
Somogyi, A. [15 ]
Quartier, P. [16 ]
Mariette, X.
机构：
[1] Bicetre Hosp Le Kremlin, Le Kremlin Bicetre, France
[2] Peyronie Hosp, Montpellier, France
[3] Cochin Hosp, Paris, France
[4] Nantes Hosp, Nantes, France
[5] Lille Hosp, Lille, France
[6] Cochin Hosp, Paris, France
[7] St Etienne Hosp, St Etienne, France
[8] La Pitie Salpetriere Hosp, Paris, France
[9] Robert Ballanger Hosp, Aulnay Sous Bois, France
[10] Strasbourg Hosp, Strasbourg, France
[11] Internal Med Jean Verdier Hosp, Bondy, France
[12] Avicenne Hosp, Bobigny, France
[13] Grenoble Hosp, Grenoble, France
[14] Mulhouse Hosp, Mulhouse, France
[15] St Germain Laye Hosp, St Gernmain En Laye, France
[16] Hop Necker Enfants Malad, Paris, France
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2007年 / 66卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：431 / 431
页数：1
相关论文
共 50 条
  • [21] Long-term safety data from extended follow-up and repeat use of rituximab in rheumatoid arthritis
    van Vollenhoven, R.
    Emery, R.
    Bingham, C.
    Keystone, E.
    Greenwald, M.
    Moreland, L. W.
    Sweetser, M.
    Rowe, K.
    Wagner, B.
    Magrini, F.
    ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 : 88 - 89
  • [22] Efficacy and safety of rituximab treatment in early primary Sjogren's syndrome: a prospective, multi-center, follow-up study
    Carubbi, Francesco
    Cipriani, Paola
    Marrelli, Alessandra
    Di Benedetto, Paola
    Ruscitti, Piero
    Berardicurti, Onorina
    Pantano, Ilenia
    Liakouli, Vasiliki
    Alvaro, Saverio
    Alunno, Alessia
    Manzo, Antonio
    Ciccia, Francesco
    Gerli, Roberto
    Triolo, Giovanni
    Giacomelli, Roberto
    ARTHRITIS RESEARCH & THERAPY, 2013, 15 (05)
  • [23] Efficacy and safety of rituximab treatment in early primary Sjögren's syndrome: a prospective, multi-center, follow-up study
    Francesco Carubbi
    Paola Cipriani
    Alessandra Marrelli
    Paola Di Benedetto
    Piero Ruscitti
    Onorina Berardicurti
    Ilenia Pantano
    Vasiliki Liakouli
    Saverio Alvaro
    Alessia Alunno
    Antonio Manzo
    Francesco Ciccia
    Roberto Gerli
    Giovanni Triolo
    Roberto Giacomelli
    Arthritis Research & Therapy, 15
  • [24] Long-term safety data from extended follow-up and repeat use of Rituximab (RTX) in patients with active rheumatoid arthritis (RA)
    Ronald, Van Vollenhoven
    Tore, Kvien
    Jean, Sibilia
    Paul, Emery
    Clifton, Bingham
    Edward, Keystone
    Maria, Greenwald
    Larry, Moreland
    Marrianne, Sweetser
    Karen, Rowe
    Bridget, Wagner
    Fabio, Magrini
    SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2008, 37 : 51 - 51
  • [25] Safety and Efficacy Of Rituximab In adult's Immune Thrombocytopenia (ITP) : Results After One-Year Of Follow-Up In 252 Patients From The Prospecthe French ITP-Ritux Registry
    Khellaf, Mehdi
    Fain, Olivier
    Terriou, Louis
    Viallard, Jean-Francois
    Cheze, Stephane
    Francoise, Roudot-Thoraval
    Hamidou, Mohamed
    Slama, Borhane
    Audia, Sylvain
    Schleinitz, Nicolas
    Cliquennois, Manuel
    le Guenno, Guillaume
    Bonmati, Caroline
    Teillet, France
    Lambotte, Olivier
    Maigne, Gwenola
    Galicier, Lionel
    Hot, Arnaud
    Lefrere, Francois
    Adoue, Daniel
    Bordessoule, Dominique
    Delbrel, Xavier
    Bouscary, Didier
    Cahn, Jean-Yves
    Ghali, Alas
    Verrot, Denis
    Delmer, Alain
    Jego, Patrick
    Magnant, Julie
    Buchdahl, Anne-Laure
    Royer, Bruno
    Rosenstingl, Sophie
    Durand, Jean-Marc
    Bierling, Philippe
    Michel, Marc
    Godeau, Bertrand
    BLOOD, 2013, 122 (21)
  • [26] Switching From Rituximab to Abatacept: Tolerance Data of 203 Patients Prospectively Followed up in the (Orencia) and Rheumatoid Arthritis (ORA) Registry.
    Gottenberg, Jacques-Eric
    Schaeverbeke, Thierry
    Gaudin, Philippe
    Euller-Ziegler, Liana E.
    Thao Pham
    Flipo, Rene-Marc
    Cantagrel, Alain G.
    Houvenagel, Eric
    Redecker, S.
    Le Loet, Xavier X.
    Claudepierre, Pascal
    Pane, Isabelle
    Ravaud, Philippe
    Mariette, Xavier
    ARTHRITIS AND RHEUMATISM, 2011, 63 (10): : S873 - S874
  • [27] OUTPATIENT REGISTRY OF CARDIOVASCULAR DISEASES (RECVASA): PROSPECTIVE FOLLOW-UP DATA, ESTIMATION OF RISKS AND OUTCOMES IN PATIENTS WITH ATRIAL FIBRILLATION
    Loukianov, M. M.
    Boytsov, S. A.
    Yakushin, S. S.
    Martsevich, S. Yu.
    Vorobyev, A. N.
    Zagrebelnyy, A. V.
    Kharlap, M. S.
    Pereverzeva, K. G.
    Pravkina, E. A.
    Serdyuk, S. E.
    Deev, A. D.
    Kudryashov, E. N.
    RATIONAL PHARMACOTHERAPY IN CARDIOLOGY, 2014, 10 (05) : 470 - 480
  • [28] Can efficacy and safety data from clinical trials of rituximab in RA be extrapolated? Insights from 1984 patients from the AIR-PR Registry
    Nguyen, Yann
    Mariette, Xavier
    Gottenberg, Jacques E.
    Iudici, Michele
    Morel, Jacques
    Vittecoq, Olivier
    Constantin, Arnaud
    Flipo, Rene-Marc
    Schaeverbeke, Thierry
    Sibilia, Jean
    Ravaud, Philippe
    Porcher, Raphael
    Seror, Raphaele
    RHEUMATOLOGY, 2023, 63 (07) : 1893 - 1901
  • [29] Can efficacy and safety data from clinical trials of rituximab in RA be extrapolated? Insights from 1984 patients from the AIR-PR Registry
    Nguyen, Yann
    Mariette, Xavier
    Gottenberg, Jacques E.
    Iudici, Michele
    Morel, Jacques
    Vittecoq, Olivier
    Constantin, Arnaud
    Flipo, Rene-Marc
    Schaeverbeke, Thierry
    Sibilia, Jean
    Ravaud, Philippe
    Porcher, Raphael
    Seror, Raphaele
    RHEUMATOLOGY, 2023, : 1893 - 1901
  • [30] In Rheumatoid Arthritis (RA) Patients, Retreatment with Rituximab (RTX) at Half Dose Does Not Alter Maintenance on Drug and Allows One Third Reduction of Cumulative Dose of Drug/Year: Data from the Autoimmunity and Rituximab (AIR) Registry
    Henry, Julien
    Pavy, Stephane
    Gottenberg, Jacques
    Belkhir, Rakiba
    Rouanet, Stephanie
    Sellam, Jeremie
    Mariette, Xavier
    Seror, Raphaele
    ARTHRITIS & RHEUMATOLOGY, 2015, 67
12345